GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Scott Borchetta, the 63-year-old music mogul who is credited for discovering Taylor Swift, shrugged off the graduates' disapproval, saying they would regret not listening to him at Middle Tennessee St...
Life on the set of “The Madison” was far less glamorous than viewers might expect, according to actress Michelle Pfeiffer,...
An Indiana woman, 75-year-old Anita Grayson, died after getting into a fight with a Fort Wayne Tim Hortons manager, caught on surveillance video....
